Further Information
Ubiquitin-conjugating enzyme E2 G1, E217K, UBC7, Ubiquitin carrier protein G1, Ubiquitin-protein ligase G1, Ubiquitin-conjugating enzyme E2 G1, N-terminally processed, UBE2G1, UBE2G
For WB starting dilution is: 1:1000
The modification of proteins with ubiquitin is an
important cellular mechanism for targeting abnormal or short-lived
proteins for degradation. Ubiquitination involves at least three
classes of enzymes: ubiquitin-activating enzymes, or E1s,
ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein
ligases, or E3s. This gene encodes a member of the E2
ubiquitin-conjugating enzyme family and catalyzes the covalent
attachment of ubiquitin to other proteins. The protein may be
involved in degradation of muscle-specific proteins. [provided by
RefSeq].
- Hassink, G., et al. Biochem. J. 388 (PT 2), 647-655 (2005) :
- Kim, B.W., et al. Mol. Endocrinol. 17(12):2603-2612(2003)
- Gevaert, K., et al. Nat. Biotechnol. 21(5):566-569(2003)
- Imai, Y., et al. Cell 105(7):891-902(2001)
Supplied in PBS with 0.09% (W/V) sodium azide.
batch dependent
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Predicted species reactivity based on immunogen sequence: Monkey, Mouse, Rat
This UBE2G1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 127-155 amino acids from the C-terminal region of human UBE2G1.
7326
Ubiquitin-conjugating enzyme E2 G1
UBE2G1
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
20 kDa
P62253
51338681
This antibody is purified through a protein A column, followed by peptide affinity purification.
Cell Cycle
P62253
Optimal dilutions for each application to be determined by the researcher.